$27.62
1.043.91%
al cierre: -
$27.10
-0.52-1.88%
After hour: 4:57 PM EDT
Comments
Loading...
Apellis Pharmaceuticals Informe de interés a corto plazo
APLSNASDAQ
Informe de interés en corto
El interés corto en Apellis Pharmaceuticals Inc (NASDAQ:APLS) ha aumentado durante el último período de informe, aumentando en aumento desde 16.49M hasta 22.09M. Esto representa el 23.04% de las acciones disponibles públicamente de la empresa.
El interés en corto en Apellis Pharmaceuticals Corp (XNAS:APLS) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 3.04M acciones negociadas por día, tomaría 7.26 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
22.09M
Interés en corto %
23.0%
Días para cubrir
7.26
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 23.04% | 95,884,373 | 22,092,024 | 3,044,053 | 7.26 | |
APLS | Apellis Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 17.31% | 95,276,723 | 16,492,598 | 1,948,010 | 8.47 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 27.45% | 95,276,723 | 26,148,815 | 1,867,422 | 14 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 26.39% | 95,276,723 | 25,140,355 | 2,268,431 | 11.08 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 26.28% | 95,276,723 | 25,034,198 | 2,513,498 | 9.96 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 28.60% | 95,276,723 | 27,245,432 | 3,360,369 | 8.11 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 30.20% | 95,276,723 | 28,771,303 | 2,263,456 | 12.71 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 28.16% | 95,276,723 | 26,833,210 | 3,081,613 | 8.71 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 24.48% | 91,955,446 | 22,511,249 | 2,165,571 | 10.4 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 21.00% | 91,955,446 | 19,313,821 | 1,465,315 | 13.18 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 22.64% | 91,955,446 | 20,815,049 | 1,738,206 | 11.98 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 19.09% | 90,832,650 | 17,341,085 | 1,439,758 | 12.04 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 18.78% | 90,832,650 | 17,055,810 | 1,473,551 | 11.57 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 19.86% | 90,832,650 | 18,039,735 | 2,522,912 | 7.15 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 24.35% | 88,205,961 | 21,477,949 | 2,152,590 | 9.98 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 22.69% | 88,205,961 | 20,011,664 | 3,061,511 | 6.54 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 24.73% | 88,205,961 | 21,811,296 | 4,485,961 | 4.86 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 26.28% | 88,205,961 | 23,182,889 | 4,450,930 | 5.21 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 23.57% | 88,205,961 | 20,786,277 | 2,084,705 | 9.97 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 23.91% | 88,205,961 | 21,088,064 | 3,827,807 | 5.51 | |
APLS | Apellis Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 17.30% | 88,205,961 | 15,260,698 | 2,289,442 | 6.67 | |
APLS | Apellis Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 17.33% | 88,205,961 | 15,284,852 | 1,397,862 | 10.93 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 18.34% | 88,205,961 | 16,173,529 | 826,033 | 19.58 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/15/2024 | 08/26/2024 | 18.44% | 88,205,961 | 16,267,681 | 2,141,166 | 7.6 | |
APLS | Apellis Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 18.04% | 88,205,961 | 15,916,603 | 1,373,160 | 11.59 | |
APLS | Apellis Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 17.28% | 87,805,188 | 15,168,402 | 1,352,038 | 11.22 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 16.87% | 87,805,188 | 14,814,085 | 1,802,742 | 8.22 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 15.83% | 87,805,188 | 13,899,907 | 872,302 | 15.93 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 14.94% | 87,805,188 | 13,116,801 | 1,415,017 | 9.27 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 14.33% | 87,805,188 | 12,586,479 | 1,669,061 | 7.54 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 14.11% | 87,805,188 | 12,388,136 | 1,736,373 | 7.13 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 12.16% | 87,733,401 | 10,669,213 | 1,147,476 | 9.3 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 10.05% | 103,890,033 | 10,439,851 | 1,098,740 | 9.5 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 10.19% | 103,890,033 | 10,591,406 | 1,391,553 | 7.61 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 9.69% | 103,890,033 | 10,064,166 | 1,408,971 | 7.14 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/15/2024 | 02/27/2024 | 10.09% | 101,808,229 | 10,270,787 | 1,503,091 | 6.83 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 10.48% | 101,808,229 | 10,669,463 | 1,568,794 | 6.8 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 11.82% | 101,808,229 | 12,034,038 | 2,288,740 | 5.26 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 11.48% | 101,808,229 | 11,688,661 | 1,792,077 | 6.52 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 12.75% | 101,808,229 | 12,977,948 | 3,887,528 | 3.34 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 14.99% | 101,808,229 | 15,264,853 | 1,464,068 | 10.43 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 15.85% | 101,808,229 | 16,137,939 | 2,143,822 | 7.53 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/31/2023 | 11/09/2023 | 15.94% | 101,808,229 | 16,231,193 | 1,694,169 | 9.58 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/13/2023 | 10/24/2023 | 18.40% | 101,045,573 | 18,593,076 | 2,940,235 | 6.32 | |
APLS | Apellis Pharmaceuticals, Inc. | 09/29/2023 | 10/10/2023 | 16.60% | 101,045,573 | 16,773,363 | 3,627,479 | 4.62 | |
APLS | Apellis Pharmaceuticals, Inc. | 09/15/2023 | 09/26/2023 | 13.47% | 101,045,573 | 13,609,851 | 1,850,811 | 7.35 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/31/2023 | 09/12/2023 | 12.18% | 101,045,573 | 12,306,670 | 3,441,592 | 3.58 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/15/2023 | 08/24/2023 | 13.60% | 101,045,573 | 13,746,602 | 7,249,918 | 1.9 |
En busca de los valores más cortos?